Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LIFE

aTyr Pharma (LIFE) Stock Price, News & Analysis

aTyr Pharma logo

About aTyr Pharma Stock (NASDAQ:LIFE)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.57
$2.07
52-Week Range
N/A
Volume
269,400 shs
Average Volume
514,103 shs
Market Capitalization
$131.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LIFE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for aTyr Pharma and its competitors with MarketBeat's FREE daily newsletter.

LIFE Stock News Headlines

1 Small-Cap Biotech Stock Poised for a Breakout
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
aTyr: Promising Data, But Cash May Be An Issue
See More Headlines

LIFE Stock Analysis - Frequently Asked Questions

aTyr Pharma, Inc. (NASDAQ:LIFE) released its quarterly earnings results on Thursday, May, 2nd. The biotechnology company reported ($0.23) earnings per share for the quarter, beating analysts' consensus estimates of ($0.24) by $0.01. The biotechnology company had revenue of $0.24 million for the quarter, compared to analyst estimates of $0.11 million.

aTyr Pharma shares reverse split before market open on Monday, July 1st 2019.The 1-14 reverse split was announced on Friday, June 28th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 28th 2019. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

aTyr Pharma (LIFE) raised $76 million in an IPO on Thursday, May 7th 2015. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Citigroup served as the underwriters for the IPO and BMO Capital Markets and William Blair were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that aTyr Pharma investors own include Tesla (TSLA), Plug Power (PLUG), Meta Platforms (META), NVIDIA (NVDA), SCYNEXIS (SCYX), Ford Motor (F) and NIO (NIO).

Company Calendar

Last Earnings
5/02/2024
Today
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:LIFE
CIK
1339970
Employees
56
Year Founded
2005

Profitability

EPS (Trailing Twelve Months)
($0.90)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$50.39 million
Net Margins
N/A
Pretax Margin
-9,172.11%
Return on Equity
-56.92%
Return on Assets
-43.87%

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
6.07
Quick Ratio
6.07

Sales & Book Value

Annual Sales
$350 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.54 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
69,010,000
Free Float
66,458,000
Market Cap
$131.12 million
Optionable
Optionable
Beta
1.19

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:LIFE) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners